Company Spotlight

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Adare Pharma Solutions

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Alcami

4620 Creekstone Drive
Durham, NC 27703
United States
View Profile


Contract Service Directory


AB BioTechnologies, Inc.





Company Headquarters

3770 Jonathan Drive
Bloomington, IN 47404
United States

Contract Service Directory

    Related Content

    • Regulatory Affairs | Serialization
      Fighting Back!

      Fighting Back!

      The drug industry takes a bare-knuckle approach to drug counterfeiters.
      Daniela Geiger, Vetter 10.04.19

    • Industry News | Promotions & Moves

      Metrics Names Associate Director of Pharma Development

      Yogesh Sadhale to manage all aspects of formulation development and manufacturing of a client’s clinical trial materials
      12.04.17

    • cGMP Manufacture | Clinical Trial Materials | Drug Development | Formulation Development | Industry News
      Quotient Clinical Launches New Identity

      Quotient Clinical Launches New Identity

      New identity depicts extended range of services following acquisitions of Co-Formulate, QS Pharma and SeaView Research
      11.10.17


    • Promotions & Moves
      AB BioTechnologies Appoints Two New Directors

      AB BioTechnologies Appoints Two New Directors

      The new executives will lead Quality, Validation, and IT, in addition to Operations and Facilities
      11.08.17

    • Biologics, Proteins, Vaccines | Injectables
      A World of Innovation

      A World of Innovation

      The importance of innovation in the injectable business and the hurdles a CDMO faces
      Claudia Roth, Vetter Pharma-Fertigung GmbH & Co. KG 11.07.17

    • Formulation Development | Industry News
      Quotient Clinical, Nuformix Ink Cocrystal Formulation Pact

      Quotient Clinical, Nuformix Ink Cocrystal Formulation Pact

      Will use Translational Pharmaceutics platform to develop and validate a formulated oral NXP001 cocrystal product
      10.19.17


    • Industry News
      CPhI Report Highlights Anticipated CDMO Market Trends

      CPhI Report Highlights Anticipated CDMO Market Trends

      Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated
      10.17.17

    • Drug Delivery Innovation

      Growth in biologics is driving advanced drug delivery technology solutions
      Tim Wright, Editor 10.11.17

    • Bio News | Bioanalytical Services | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      ABL Acquisition Extends Ardena’s Early-phase Offering

      ABL Acquisition Extends Ardena’s Early-phase Offering

      Broadens the CDMO’s pre-clinical and clinical offering to include bioanalytical and drug discovery services.
      10.10.17


    • Breaking News | Clinical Trial Materials | Drug Development | Industry News
      Ardena Launches following Pharmavize and Crystallics Merger

      Ardena Launches following Pharmavize and Crystallics Merger

      Will offer solid-state chemistry, analytical and formulation development, and early-phase clinical supply manufacturing
      09.11.17

    • Aseptic Processing | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Injectables
      Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

      Amatsigroup Manufactures Injectable Clinical Batch Under Single-Use Isolator

      French CDMO develops innovative single-use technology solutions for aseptic formulation & manufacturing
      09.05.17

    • APIs | Breaking News | Clinical Trial Materials | Facilities | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      WuXi’s PDS Division Merges with STA

      WuXi’s PDS Division Merges with STA

      Tie-up creates a full service CDMO
      07.31.17


    • Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Eurofins to Acquire Amatsigroup for $150M

      Eurofins to Acquire Amatsigroup for $150M

      Expands position in biopharmaceutical services
      07.12.17